Review: taking Singulair and Macrobid together


Summary

Drug interactions are reported among people who take Singulair and Macrobid together. This review analyzes the effectiveness and drug interactions between Singulair and Macrobid. It is created by eHealthMe based on reports of 204 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Singulair

Singulair has active ingredients of montelukast sodium. It is often used in asthma. (latest outcomes from Singulair 61,069 users)

Macrobid

Macrobid has active ingredients of nitrofurantoin; nitrofurantoin, macrocrystalline. It is often used in urinary tract infection. (latest outcomes from Macrobid 4,768 users)

On Sep, 15, 2016

204 people who take Singulair, Macrobid are studied.


Number of reports submitted per year:

Singulair and Macrobid drug interactions.

Drug effectiveness over time:

Singulair:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 100.0% - (1 of 1 people)
  • not specified: 0.0% - (0 of 0 people)
Macrobid:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Singulair:
  • female: 50.0% - (1 of 2 people)
  • male: 0.0% - (0 of 0 people)
Macrobid:
  • female: 0.0% - (0 of 2 people)
  • male: 0.0% - (0 of 0 people)

Drug effectiveness by age:

Singulair:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 50.0% - (1 of 2 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)
Macrobid:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 2 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • dizziness
  • metabolic acidosis
  • renal tubular necrosis
  • somnolence
  • swelling
  • calculus ureteric
  • cardiorenal syndrome
  • decreased appetite
  • feeling abnormal
  • nephrolithiasis
1 - 6 months:
  • intestinal perforation
  • constipation
2 - 5 years:
  • shingles
10+ years:
  • cardiac disorder
  • dyspepsia
  • fatigue
  • gallbladder disorder
  • gastrointestinal disorder
  • pain
  • cholelithiasis
  • cholecystitis chronic
not specified:
  • fatigue
  • pain
  • muscle spasms
  • back pain
  • oedema peripheral
  • fall
  • urinary tract infection
  • gait disturbance
  • pneumonia
  • weight increased

Most common drug interactions by gender *:

female:
  • fatigue
  • pain
  • back pain
  • fall
  • oedema peripheral
  • dizziness
  • muscle spasms
  • urinary tract infection
  • somnolence
  • arthralgia
male:
  • drug exposure during pregnancy
  • congenital aortic atresia
  • hypoplastic left heart syndrome
  • mitral valve stenosis
  • muscle spasms
  • malaise
  • pneumonia
  • abdominal discomfort
  • anxiety
  • asthenia

Most common drug interactions by age *:

2-9:
  • lethargy
  • blood glucose decreased
  • encephalopathy
  • fall
  • hypotension
  • hypothermia
  • pneumonia
  • sedation
  • septic shock
  • tachycardia
10-19:
  • drug ineffective
  • gallbladder operation
  • gastrointestinal injury
  • hospitalisation
  • injury
  • pain
  • pregnancy with contraceptive device
  • procedural pain
  • uterine perforation
20-29:
  • deep vein thrombosis
  • chest pain
  • musculoskeletal pain
  • pain in extremity
  • pulmonary embolism
  • injury
  • pain
  • pneumonia
  • anxiety
  • bronchial hyperreactivity
30-39:
  • fatigue
  • pain
  • cardiac disorder
  • dyspepsia
  • gallbladder disorder
  • gastrointestinal disorder
  • cholelithiasis
  • diabetes mellitus
  • insomnia
  • dizziness
40-49:
  • fatigue
  • pain
  • headache
  • weight increased
  • abdominal pain
  • arthralgia
  • drug ineffective
  • dysphagia
  • injury
  • oedema peripheral
50-59:
  • psychotic disorder
  • injection site bruising
  • dyspnoea
  • hallucination, auditory
  • headache
  • paranoia
  • urinary tract infection
  • blood creatinine increased
  • feeling abnormal
  • hepatic enzyme increased
60+:
  • fatigue
  • urinary tract infection
  • dizziness
  • dyspnoea
  • metabolic acidosis
  • nausea
  • renal tubular necrosis
  • fall
  • feeling abnormal
  • cardiorenal syndrome

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Singulair and Macrobid?

Can you answer these questions?

More questions for: Singulair, Macrobid

You may be interested in these reviews

More reviews for: Singulair, Macrobid

On eHealthMe, Singulair (montelukast sodium) is often used to treat asthma. Macrobid (nitrofurantoin; nitrofurantoin, macrocrystalline) is often used to treat urinary tract infection. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.